首页> 外文期刊>General Pharmacology >Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
【24h】

Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.

机译:具有血管舒张特性的醛型α/β-肾上腺素受体阻断剂的药理作用。

获取原文
获取原文并翻译 | 示例
       

摘要

KMUP 880723 (0.5, 1.0, and 3.0 mg/kg, iv) produced dose-dependent hypotensive and bradycardia responses in pentobarbital-anesthetized Wistar rats. KMUP 880723 (1.0 mg/kg, iv) also markedly inhibited both the tachycardia effects induced by (-)isoproterenol and arterial pressor responses induced by phenylephrine. In the isolated Wistar rat right atria, left atria, and guinea pig tracheal strips, KMUP 880723 competitively antagonized the (-)isoproterenol-induced positive chronotropic effects, inotropic effects, and tracheal relaxation effects in a concentration-dependent manner. The parallel shift to the right of the concentration-response curve of (-)isoproterenol suggested that KMUP 880723 was a beta(1)/beta(2)-adrenoceptor competitive antagonist. The apparent pA(2) values were 6.89+/-0.10 in the right atria, 7.02+/-0.09 in the left atria, and 6.59+/-0.11 in the trachea, indicating that KMUP 880723 was a nonselective beta-adrenoceptor blocker. In thoracic aorta experiments, KMUP 880723 also produced a competitive antagonism of norepinephrine-induced contraction with a pA(2) value of 7.14+/-0.06. In isolated rat thoracic aorta, KMUP 880723 more potently relaxed the contractions induced by norepinephrine (3 x 10(-6) M) than those by high K(+) (75 mM). In the radioligand-binding assay, the pK(i) values of [3H]CGP-12177 binding to rat ventricle and lung membranes were 6.56 and 6.40, respectively, and the value of [3H]prazosin binding to rat brain membranes was 6.66. These results further confirmed the alpha/beta-adrenoceptor blocking activities of KMUP 880723 reported in the functional studies. We conclude that KMUP 880723 is a nonselective beta-adrenoceptor antagonist with alpha-adrenoceptor blocking-associated vasorelaxant activity.
机译:KMUP 880723(0.5、1.0和3.0 mg / kg,静脉注射)在戊巴比妥麻醉的Wistar大鼠中产生剂量依赖性的降压和心动过缓反应。 KMUP 880723(1.0 mg / kg,iv)还显着抑制由(-)异丙肾上腺素引起的心动过速效应和去氧肾上腺素引起的动脉升压反应。在分离的Wistar大鼠右心房,左心房和豚鼠气管带中,KMUP 880723以浓度依赖的方式竞争性拮抗(-)异丙肾上腺素诱导的正变时作用,变力作用和气管舒张作用。平行移动到(-)异丙肾上腺素的浓度-反应曲线的右边表明KMUP 880723是一个beta(1)/ beta(2)-肾上腺素受体竞争性拮抗剂。 pA(2)的表观值在右心房为6.89 +/- 0.10,在左心房为7.02 +/- 0.09,在气管中为6.59 +/- 0.11,表明KMUP 880723是一种非选择性β-肾上腺素受体阻滞剂。在胸主动脉实验中,KMUP 880723还产生了去甲肾上腺素诱导的收缩的竞争性拮抗作用,pA(2)值为7.14 +/- 0.06。在分离的大鼠胸主动脉中,KMUP 880723比高K(+)(75 mM)更有效地缓解了去甲肾上腺素(3 x 10(-6)M)引起的收缩。在放射性配体结合测定中,[3H] CGP-12177与大鼠心室和肺膜结合的pK(i)值分别为6.56和6.40,[3H]哌唑嗪与大鼠脑膜结合的pK(i)值为6.66。这些结果进一步证实了功能研究中报道的KMUP 880723的α/β-肾上腺素受体阻断活性。我们得出结论,KMUP 880723是一种非选择性的β-肾上腺素受体拮抗剂,具有与α-肾上腺素受体阻断相关的血管舒张活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号